Kumquat Biosciences and Takeda Enter into Strategic Collaboration and Exclusive Global License Agreement to Advance Novel Oral Immuno-Oncology Drug Candidate

Kumquat to lead research and clinical development into Phase 1 Kumquat has an option to co-develop and share in U.S. for profit/loss SAN DIEGO, April 16, 2024 /PRNewswire/ — Kumquat Biosciences, a leader in translating breakthrough science into first-in-class therapeutics, announced…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.